These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27007528)

  • 1. Differences in achieving treatment goals with statin use in various regions of Poland--3ST-POL study results.
    Śliż D; Filipiak KJ; Naruszewicz M; Siebert J; Mamcarz A
    Ann Agric Environ Med; 2016; 23(1):116-9. PubMed ID: 27007528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standards of statin usage in Poland in high-risk patients: 3ST-POL study results.
    Sliż D; Filipiak KJ; Naruszewicz M; Siebert J; Mamcarz A
    Kardiol Pol; 2013; 71(3):253-9. PubMed ID: 23575780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difference in efficacy of dyslipidaemia treatment in obese and not obese women. Analysis of date from 3ST-POL study].
    Wełnicki M; Śliż D; Filipiak KJ; Szeligowska J; Naurszewicz M; Siebert J; Mamcarz A
    Przegl Lek; 2016; 73(6):353-8. PubMed ID: 29668197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA; Ruiz A; Cardona-Muñoz EG; Silva JM; Fuenmayor N; Marotti M;
    Curr Med Res Opin; 2005 Aug; 21(8):1307-15. PubMed ID: 16083541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol, statins, and longevity from age 70 to 90 years.
    Jacobs JM; Cohen A; Ein-Mor E; Stessman J
    J Am Med Dir Assoc; 2013 Dec; 14(12):883-8. PubMed ID: 24094647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical gap between recommended and achieved LDL-cholesterol levels. Results of statin therapy in Slovakia.
    Gajdos M; Krivosikova Z; Uhliar R
    Bratisl Lek Listy; 2007; 108(9):388-92. PubMed ID: 18225475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
    Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
    Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis.
    Ambegaonkar BM; Tipping D; Polis AB; Tomassini JE; Tershakovec AM
    Atherosclerosis; 2014 Dec; 237(2):829-37. PubMed ID: 25463129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Davidson MH
    Clin Ther; 2007 Nov; 29(11):2385-94. PubMed ID: 18158079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].
    Degli Esposti L; Sangiorgi D; Arca M; Vigna GB; Budal S; Degli Esposti E
    Monaldi Arch Chest Dis; 2011 Dec; 76(4):160-7. PubMed ID: 22567731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.
    Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R
    Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulatory RAS activity can be inhibited by statins in patients with hypercholesterolemia.
    Long H; Wang L; Su H; Xu J; Li J; Peng Q; Dong Y; Cheng X
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):126-30. PubMed ID: 23539660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
    Devroey D; Velkeniers B; Duquet W; Betz W
    Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care.
    Lee JA; Sunwoo S; Kim YS; Oh HJ; Kang HC; Park KC; Sin DH; Lee SY; Yang YJ; Yu BY; Kim CM
    Curr Med Res Opin; 2013 Jul; 29(7):751-60. PubMed ID: 23647398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of phosphodiesterase type 5 inhibitor treatment in men with erectile dysfunction and dyslipidemia: a post hoc analysis of the vardenafil statin study.
    Miner MM; Barnes A; Janning S
    J Sex Med; 2010 May; 7(5):1937-47. PubMed ID: 20202105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.